Evidence map›Paper›PMID 41113171›Full record

ArticleIn silico pharmacology2025

Comprehensive bioinformatics analysis of omics data to reveal molecular mechanisms and biomarkers in multiple cancers.

Mijan Mia, Tonima Rahman Tuli, Kazi Musfika Binte Absar, Arifa Afrose Rimi, Sumiya Ahmad Sejuti, Adrita Noumi Arshi, Md Emdadul Islam, Ahsan Habib

Abstract read
In one paragraph

Article in In silico pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mijan Mia *Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna, 9208 Bangladesh.
Tonima Rahman Tuli *Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna, 9208 Bangladesh.
Kazi Musfika Binte AbsarDepartment of Pharmacy, University of Science and Technology Chittagong (USTC), Chittagong, 4202 Bangladesh.
Arifa Afrose RimiBiotechnology and Genetic Engineering Discipline, Khulna University, Khulna, 9208 Bangladesh.
Sumiya Ahmad SejutiBiotechnology and Genetic Engineering Discipline, Khulna University, Khulna, 9208 Bangladesh.
Adrita Noumi ArshiBiotechnology and Genetic Engineering Discipline, Khulna University, Khulna, 9208 Bangladesh.
Md Emdadul IslamBiotechnology and Genetic Engineering Discipline, Khulna University, Khulna, 9208 Bangladesh.
Ahsan HabibBiotechnology and Genetic Engineering Discipline, Khulna University, Khulna, 9208 Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast, ovarian, lung, cervical, and colorectal cancers are among the most prevalent malignancies affecting women worldwide. This study aimed to elucidate the common molecular mechanisms of tumorigenesis and identify potential biomarkers using an integrative bioinformatics and network-based approach. Integrative profiling of five microarray datasets identified 66 differentially expressed genes (DEGs) that are common across five cancer types. Gene ontology and KEGG pathway analyses of common DEGs were performed using the DAVID database. The cell cycle processes were the most enriched functions, and oocyte meiosis, oocyte maturation, the p53 signaling pathway, cancer pathways, and cellular senescence were the most important pathways identified. Protein-protein interaction (PPI) networks for the DEGs were constructed using the STRING database, and the resulting networks were visualized in Cytoscape. Through PPI network analysis, ten hub genes were identified, and subsequent survival analysis confirmed that CHEK1, DLGAP5, CCNB2, and CCNA2 are significantly associated with poor patient survivability, establishing them as common biomarkers across multiple cancer types. Subsequently, ten transcription factors (TFs) and ten post-transcriptional regulators were identified through the assessment of regulatory networks involving TFs-DEGs and miRNAs-DEGs. Finally, drug-gene association analysis from the GSCA library was used to anticipate drug-like compounds using the drug repurposing approach. Overall, this comprehensive investigation holds promise for future in vitro and in vivo studies, offering a molecular foundation for the diagnosis, prognosis, and treatment of malignant cancers. Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-025-00440-3.

Indexed as

BiomarkerDifferentially expressed genesHub genesOmics data analysisSurvival analysis

Identifiers

PMID41113171
PMCPMC12534660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.